References
- Ginzler E M., Schorn K. Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14: 67–78
- Ginzler E, Berg A. Mortality in systemic lupus erythematosus. J Rheumatol 1987; 14: 218–22
- Halberg P, Alsbjorn B, Trolle Balslev J, et al. Systemic lupus erythematosus: Follow-up study of 148 patients. I: Classification, clinical and laboratory findings, course and outcome. Clin Rheumatol 1987; 6: 13–21
- Swaak A JG, Nossent J C., Bronsveld W, et al. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48: 447–54
- Bresnihan B. Outcome and survival in systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 443–5
- Halberg P, Alsbjorn B, Trolle Balslev J, et al. Systemic lupus erythematosus. Follow-up study of 148 patients. II. Predictive factors of importance for course an outcome. Clin Rheumatol 1987; 6: 22–6
- Swaak A JG, Nossent J C., Bronsveld W, et al. Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48: 455–60
- Helve T. Lupus erythematosus disseminatus. Prevalence in Finland, immunologic monitoring and prognosis. Thesis, Helsinki 1984
- Helve T, Teppo A-M, Kurki P, Wegelius O. Circulating DNA-antibodies in systemic lupus erythematosus. Rheumatol Int 1982; 2: 103–6
- Helve T, Kurki P, Teppo A-M, Wegelius O. DNA antibodies and complement in SLE patients. A follow-up study. Rheumatol Int 1983; 3: 129–32
- Helve T, Gripenberg M, Kurki P, Teppo A-M, Wegelius O. Enzyme-linked immunosorbent assays for antibodies to poly(A), poly dAT and histones: possibly useful tools for the evaluation of prognosis and disease activity in systemic lupus erythematosus. Rheumatol Int 1984; 4: 75–8
- Swaak A JG, Groenwold J, Aarden L A., Statius van Eps L W., Feltkamp T EW. Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 1982; 41: 388–95
- Gripenberg M, Leirisalo M, Johansson E, Gripenberg G. Assessment of class-specific antibodies against denatured DNA in patients with systemic lupus erythematosus. J Clin Immunol 1985; 5: 314–20
- Nossent J C., Huysen V, Smeenk R JT, Swaak A JG. Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance. Ann Rheum Dis 1989; 48: 677–82
- Cronin M E., Leair D W., Jaronski S, Lightfoot R W. Simultaneous use of multiple serologic tests in assessing clinical activity in systemic lupus erythematosus. Clin Immunol Immunopathol 1989; 51: 99–109
- Nossent J C., Bronsveld W, Swaak A JG. Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48: 810–16
- Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population. Medicine 1989; 68: 141–50
- Rubin L A., Urowitz M B., Gladman D D. Mortality in systemic lupus erythematosus: The bimodal pattern revisited. Q J Med 1985; 216: 87–98
- Wallace D J., Podell T, Weiner J, Klinenberg J R., Forouzesh S, Dubois E L. Systemic lupus erythematosus - survival patterns. JAMA 1981; 245: 934–8
- Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 1985; 14: 43–6
- Pettersson T, Törnroth T, Tötterman K J., Fortelius P, Maury C PJ. AA Amyloidosis in systemic-lupus erythematosus. J Rheumatol 1987; 14: 835–8